Our primary objective was to define associations between CRP ≥2 mg/L and the risk of death from infection, cardiovascular disease, or other causes, including stratification by chronic diseases previously shown to be associated with increased risk of infection death [18]. The gene discussed is CRP; the disease is cardiovascular disorder.